perugu_vada Posted December 1, 2020 Report Posted December 1, 2020 Moderna submitted its coronavirus vaccine for regulatory approval Monday, the Food and Drug Administration confirmed — the second leading drug to pass the milestone this month. The FDA said its Vaccines and Related Biological Products Advisory Committee will convene Dec. 17 to discuss its submission. That is a week after the FDA is expected to discuss another candidate, developed by the U.S. pharma giant Pfizer and its German partner BioNTech, which has also applied for regulatory approval having observed a similar level of efficacy. Quote
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.